Canada · Delayed Price · Currency is CAD Medicure Statistics
Total Valuation
Medicure has a market cap or net worth of CAD 26.09 million. The enterprise value is 24.95 million.
| Market Cap | 26.09M |
| Enterprise Value | 24.95M |
Important Dates
The next estimated earnings date is Monday, November 23, 2026.
| Earnings Date | Nov 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Medicure has 10.44 million shares outstanding.
| Current Share Class | 10.44M |
| Shares Outstanding | 10.44M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 26.42% |
| Owned by Institutions (%) | 0.62% |
| Float | 5.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.81 |
| PB Ratio | 2.25 |
| P/TBV Ratio | 107.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.78 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.97, with a Debt / Equity ratio of 0.06.
| Current Ratio | 0.97 |
| Quick Ratio | 0.61 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.36 |
| Interest Coverage | -63.08 |
Financial Efficiency
Return on equity (ROE) is -49.88% and return on invested capital (ROIC) is -64.88%.
| Return on Equity (ROE) | -49.88% |
| Return on Assets (ROA) | -17.78% |
| Return on Invested Capital (ROIC) | -64.88% |
| Return on Capital Employed (ROCE) | -61.27% |
| Weighted Average Cost of Capital (WACC) | 10.04% |
| Revenue Per Employee | 844,105 |
| Profits Per Employee | -196,079 |
| Employee Count | 38 |
| Asset Turnover | 1.26 |
| Inventory Turnover | 5.29 |
Taxes
In the past 12 months, Medicure has paid 170,000 in taxes.
| Income Tax | 170,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +117.39% in the last 52 weeks. The beta is 1.04, so Medicure's price volatility has been similar to the market average.
| Beta (5Y) | 1.04 |
| 52-Week Price Change | +117.39% |
| 50-Day Moving Average | 1.22 |
| 200-Day Moving Average | 1.10 |
| Relative Strength Index (RSI) | 85.37 |
| Average Volume (20 Days) | 6,091 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medicure had revenue of CAD 32.08 million and -7.45 million in losses. Loss per share was -0.72.
| Revenue | 32.08M |
| Gross Profit | 12.19M |
| Operating Income | -7.25M |
| Pretax Income | -7.28M |
| Net Income | -7.45M |
| EBITDA | -5.62M |
| EBIT | -7.25M |
| Loss Per Share | -0.72 |
Balance Sheet
The company has 1.83 million in cash and 696,000 in debt, with a net cash position of 1.14 million or 0.11 per share.
| Cash & Cash Equivalents | 1.83M |
| Total Debt | 696,000 |
| Net Cash | 1.14M |
| Net Cash Per Share | 0.11 |
| Equity (Book Value) | 11.57M |
| Book Value Per Share | 1.11 |
| Working Capital | -336,000 |
Cash Flow
| Operating Cash Flow | -1.93M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.64M |
| Net Borrowing | -429,000 |
| Free Cash Flow | -1.93M |
| FCF Per Share | -0.18 |
Margins
Gross margin is 38.00%, with operating and profit margins of -22.62% and -23.23%.
| Gross Margin | 38.00% |
| Operating Margin | -22.62% |
| Pretax Margin | -22.70% |
| Profit Margin | -23.23% |
| EBITDA Margin | -17.51% |
| EBIT Margin | -22.62% |
| FCF Margin | n/a |
Dividends & Yields
Medicure does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -28.56% |
| FCF Yield | -7.38% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 2, 2012. It was a reverse split with a ratio of 0.0666666.
| Last Split Date | Nov 2, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.0666666 |
Scores
Medicure has an Altman Z-Score of -3.7 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.7 |
| Piotroski F-Score | 2 |